We bring together industry experts from the business and science community working together to bring revolutionary treatment to the mental healthcare landscape.

Team Board of directors Advisors
Doug Drysdale
Chief Executive Officer
Eric So
Co-Founder, Executive Chairman and President
Aaron Bartlone
Chief Operating Officer
Lori Challenger
Chief Compliance, Ethics & Administrative Officer
Amir Inamdar MBBS, DNB (Psych), MFPM
Chief Medical Officer
Alex Nivorozhkin Ph.D.
Chief Scientific Officer
John Kanakis
Co-Founder
Paul Glavine
Co-Founder and Chief Growth Officer
Greg Cavers
Chief Financial Officer
Gabe Fahel
Chief Legal Officer
George Tziras
Chief Business Officer
Allison House-Gecewicz
SVP, Clinical Operations
Geoff Varty Ph.D.
SVP, Research & Pre-Clinical Development
Kenneth Avery Ph.D.
SVP Chemistry & Manufacturing
Eric Hoskins
Independent Director
Dr. Anthony Back
Clinical Advisor
Theresa Firestone
Independent Director
Dr. Maurizio Fava
Clinical Advisor
Sherri M. Altshuler
Regulatory Advisor
Dr. Thomas Laughren
Clinical Advisor
Mark Lawson
Independent Director
Grant Froese
Independent Director
Mirza I. Rahman, MD, MPH, FAAFP, FACPM
SVP, Patient Safety & Pharmacovigilance
Dr. Atul Mahableshwarkar, M.D.
SVP, Clinical Development
Tom Macek, PharmD, PhD
SVP, Clinical Development
Marie Layzell
VP, CMC
Pradip Pathare Ph.D.
VP, CMC
Alex Kelman, Ph.D.
VP, Clinical Development
Marcelo Gutierrez, Ph.D.
VP Clinical Pharmacology
Erica Olson
VP, Corporate Controller
Emma Hodge
Head of Legal, Europe
Naomi Morris
Senior Director, Legal & Corporate Services
Robert Mino JD, MBA, MS
General Counsel & IP Counsel
Ryan Richardson
Director of Information Technology
Sanford R. Climan
Strategic Advisor